Connection
Midhat Farooqi to Imatinib Mesylate
This is a "connection" page, showing publications Midhat Farooqi has written about Imatinib Mesylate.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.054 |
|
|
|
-
Elsbernd A, Boulouadnine B, Ahmed A, Farooqi M, Sandritter T, Shakhnovich V, Blanding D, Demoulin JB, Thompson J. Novel Oncogenic PDGFRB Variant in Severe Infantile Myofibromatosis With Response to Imatinib Using Therapeutic Drug Monitoring. JCO Precis Oncol. 2022 Oct; 6:e2200250.
Score: 0.054